Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,556,332
-
Total 13F shares
-
3,295,238
-
Share change
-
+213,182
-
Total reported value
-
$6,621,532
-
Price per share
-
$2.00
-
Number of holders
-
21
-
Value change
-
+$429,262
-
Number of buys
-
13
-
Number of sells
-
7
Institutional Holders of Aptose Biosciences Inc. - Common Shares as of Q1 2019
As of 31 Mar 2019,
Aptose Biosciences Inc. - Common Shares was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,295,238 shares.
The largest 10 holders included
DRW Securities, LLC, MORGAN STANLEY, Virtu Financial LLC, Patriot Financial Group Insurance Agency, LLC, Nantahala Capital Management, LLC, CITADEL ADVISORS LLC, US BANCORP \DE\, Squarepoint Ops LLC, TWO SIGMA ADVISERS, LP, and Noven Financial Group, Inc..
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.